Hoese & Co LLP
- SEC CIK
- 0001840268
- Latest filing
- Jul 14, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Hoese & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −500−100.0% | Sold out | Holders |
| Q2 2025 | 500 | $34.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 500 | $34.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 500 | $43.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 500 | $59.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 500 | $67.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 500 | $59.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 500 | $50.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 500 | $45.5K | <0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 250 | $40.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 250 | $35.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 250 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 250 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 250 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 250 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 250 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 250 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 250 | $21.0K | <0.1% | +250 | New | Holders |